SCR1693

Overview

SCR1693 is a selective, reversible, orally active and noncompetitive inhibitor of AChE ( IC 50 = 0.68 μM) as well as a calcium channel blocker. SCR1693 reduces tau phosphorylation levels, and inhibits the generation and release of Aβ . SCR1693 restores insulin signaling and improves cognitive deficits. SCR1693 can be used for the study of Alzheimer's disease, especially which complicated with type 2 diabetes mellitus.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > GSK-3 | Products > Signaling Pathways > Tau Protein | Products > Signaling Pathways > Phosphatase | Products > Signaling Pathways > Akt | Products > Signaling Pathways > PKA | Products > Signaling Pathways > Amyloid-β | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-165341
• CAS No.: 1442559-20-7
• Molecular Formula: C24H28ClN3O2
• Molecular Weight: 425.95
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source